- not yet recruitingNA
Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France
This study aims to find and help people from Mongolia living in France who have hepatitis B, C, or Delta. These liver conditions are common in Mongolia and can lead to serious health problems like liver cancer if not treated. The study will offer screening and set up care for those who need it.
France - recruitingPHASE3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
This study looks at a new medicine called survodutide for adults with a liver condition called MASH and moderate to advanced liver damage. It aims to see if the medicine can improve liver health and how safe it is.
United States · Argentina · Australia - recruitingPHASE4
Fibrosis Lessens After Metabolic Surgery
This study looks at how well weight-loss surgery compares to new medicines for treating liver disease. It focuses on a condition called MASH, which is linked to being overweight and can cause liver damage.
United States · Brazil · Canada